Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects
Background Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis. Aim/Methods We aim...
Saved in:
Published in | Neurogastroenterology and motility Vol. 37; no. 1; pp. e14955 - n/a |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.01.2025
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1350-1925 1365-2982 1365-2982 |
DOI | 10.1111/nmo.14955 |
Cover
Loading…
Abstract | Background
Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis.
Aim/Methods
We aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd – 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene–based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich‐ore Ltd). Bioanalysis of the microbiome (alpha‐, beta‐diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one‐way Analysis of Variance (ANOVA) and Kruskal–Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P‐value <0.05).
Results
20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α‐diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta‐diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients.
Conclusion & Inferences
The microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident.
Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects |
---|---|
AbstractList | Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis.BACKGROUNDFunctional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis.We aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd - 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene-based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich-ore Ltd). Bioanalysis of the microbiome (alpha-, beta-diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one-way Analysis of Variance (ANOVA) and Kruskal-Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P-value <0.05).AIM/METHODSWe aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd - 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene-based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich-ore Ltd). Bioanalysis of the microbiome (alpha-, beta-diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one-way Analysis of Variance (ANOVA) and Kruskal-Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P-value <0.05).20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α-diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta-diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients.RESULTS20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α-diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta-diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients.The microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident.CONCLUSION & INFERENCESThe microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident. Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis. We aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd - 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene-based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich-ore Ltd). Bioanalysis of the microbiome (alpha-, beta-diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one-way Analysis of Variance (ANOVA) and Kruskal-Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P-value <0.05). 20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α-diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta-diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients. The microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident. Background Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis. Aim/Methods We aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd – 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene–based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich‐ore Ltd). Bioanalysis of the microbiome (alpha‐, beta‐diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one‐way Analysis of Variance (ANOVA) and Kruskal–Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P‐value <0.05). Results 20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α‐diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta‐diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients. Conclusion & Inferences The microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident. Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects BackgroundFunctional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis.Aim/MethodsWe aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd – 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene–based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich‐ore Ltd). Bioanalysis of the microbiome (alpha‐, beta‐diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one‐way Analysis of Variance (ANOVA) and Kruskal–Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P‐value <0.05).Results20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α‐diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta‐diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients.Conclusion & InferencesThe microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident. |
Author | Tziatzios, Georgios Pimentel, Mark Gkolfakis, Paraskevas Triantafyllou, Konstantinos Damoraki, Georgia Giamarellos‐Bourboulis, Evangelos J. Stylianakis, Emmanouil Leite, Gabriela Mathur, Ruchi |
AuthorAffiliation | 2 4th Department of Internal Medicine National and Kapodistrian University of Athens, Medical School Athens Greece 3 Medically Associated Science and Technology (MAST) Program Los Angeles California USA 1 Hepatogastroenterology Unit, Second Department of Internal Medicine—Propaedeutic, Research Institute and Diabetes Center, Medical School National and Kapodistrian University of Athens, “Attikon” University General Hospital Athens Greece |
AuthorAffiliation_xml | – name: 3 Medically Associated Science and Technology (MAST) Program Los Angeles California USA – name: 1 Hepatogastroenterology Unit, Second Department of Internal Medicine—Propaedeutic, Research Institute and Diabetes Center, Medical School National and Kapodistrian University of Athens, “Attikon” University General Hospital Athens Greece – name: 2 4th Department of Internal Medicine National and Kapodistrian University of Athens, Medical School Athens Greece |
Author_xml | – sequence: 1 givenname: Georgios orcidid: 0000-0002-2945-6007 surname: Tziatzios fullname: Tziatzios, Georgios organization: National and Kapodistrian University of Athens, “Attikon” University General Hospital – sequence: 2 givenname: Emmanouil surname: Stylianakis fullname: Stylianakis, Emmanouil organization: National and Kapodistrian University of Athens, Medical School – sequence: 3 givenname: Georgia surname: Damoraki fullname: Damoraki, Georgia organization: National and Kapodistrian University of Athens, Medical School – sequence: 4 givenname: Paraskevas surname: Gkolfakis fullname: Gkolfakis, Paraskevas organization: National and Kapodistrian University of Athens, “Attikon” University General Hospital – sequence: 5 givenname: Gabriela surname: Leite fullname: Leite, Gabriela organization: Medically Associated Science and Technology (MAST) Program – sequence: 6 givenname: Ruchi surname: Mathur fullname: Mathur, Ruchi organization: Medically Associated Science and Technology (MAST) Program – sequence: 7 givenname: Mark orcidid: 0000-0002-0619-5115 surname: Pimentel fullname: Pimentel, Mark organization: Medically Associated Science and Technology (MAST) Program – sequence: 8 givenname: Evangelos J. orcidid: 0000-0003-4713-3911 surname: Giamarellos‐Bourboulis fullname: Giamarellos‐Bourboulis, Evangelos J. organization: National and Kapodistrian University of Athens, Medical School – sequence: 9 givenname: Konstantinos orcidid: 0000-0002-5183-9426 surname: Triantafyllou fullname: Triantafyllou, Konstantinos email: ktriant@med.uoa.gr organization: National and Kapodistrian University of Athens, “Attikon” University General Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39491051$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kstu1TAQhi1URC-w4AWQJTawSOt7khWqKgpIhW7K2nLsyamPEjvYCdV5HZ60Tk-pAAlvxrK_-f_RzByjgxADIPSaklNazlkY4ykVrZTP0BHlSlasbdjBepekoi2Th-g45y0hRDGhXqBD3oqWEkmP0K-bW58c3kCAZGYfA87wY4FgfdhgE8ywyz5jBzPYOePsN8H33powY-f7HlIhIWMfsFuig8Lj0dsUOx9HwDaOU8z-QbaD-Q4g4H4Jdn0opNvlCabsDZ6KNYRiYIIrWWFOccB56bar60v0vDdDhleP8QR9v_x4c_G5urr-9OXi_KqygghZuRKMkMCMcYQzQ7iTqjGMy5pw3lBieNt1Sja1dWBZp6wwlNaNapiqa9XyE_Rhrzst3QjOloKSGfSU_GjSTkfj9d8_wd_qTfypKVWSCCaLwrtHhRRLE_OsR58tDIMJEJesOWW8IWVAtKBv_0G3cUmlKyslpCQto6vgmz9Leqrl9_wK8H4PlJ7nnKB_QijR627oshv6YTcKe7Zn7_wAu_-D-tvX633GPTgCvzQ |
Cites_doi | 10.21105/joss.01169 10.1038/s41592-019-0686-2 10.1093/database/baaa062 10.1111/nmo.14372 10.1159/000504090 10.3390/microorganisms8050691 10.14309/ajg.0000000000001197 10.1093/molbev/msw046 10.1093/femsec/fiab001 10.1159/000511944 10.1186/s12866-019-1617-1 10.1111/apt.15786 10.1136/gutjnl-2019-318536 10.1053/j.gastro.2016.02.011 10.3389/fimmu.2023.1242242 10.1136/gutjnl-2021-326158 10.1038/nrdp.2017.81 10.3389/fcimb.2020.00151 |
ContentType | Journal Article |
Copyright | 2024 The Author(s). published by John Wiley & Sons Ltd. 2024 The Author(s). Neurogastroenterology & Motility published by John Wiley & Sons Ltd. 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2024 The Author(s). published by John Wiley & Sons Ltd. – notice: 2024 The Author(s). Neurogastroenterology & Motility published by John Wiley & Sons Ltd. – notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK K9. 7X8 5PM |
DOI | 10.1111/nmo.14955 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | Tziatzios et al |
EISSN | 1365-2982 |
EndPage | n/a |
ExternalDocumentID | PMC11650425 39491051 10_1111_nmo_14955 NMO14955 |
Genre | researchArticle Journal Article |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 24P 29N 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DTERQ DU5 EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7TK AAMMB AEFGJ AGXDD AIDQK AIDYY K9. 7X8 5PM |
ID | FETCH-LOGICAL-c4045-dc40a45e2aad032a03d568a2357033810a39bb6587cdec2b6c4a1178682677693 |
IEDL.DBID | 24P |
ISSN | 1350-1925 1365-2982 |
IngestDate | Thu Aug 21 18:29:46 EDT 2025 Fri Jul 11 16:30:55 EDT 2025 Wed Aug 13 09:35:58 EDT 2025 Wed Feb 19 02:00:28 EST 2025 Tue Jul 01 00:43:40 EDT 2025 Wed Jan 22 17:11:56 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | functional duodenal microbiome dyspepsia |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2024 The Author(s). Neurogastroenterology & Motility published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4045-dc40a45e2aad032a03d568a2357033810a39bb6587cdec2b6c4a1178682677693 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2945-6007 0000-0002-0619-5115 0000-0002-5183-9426 0000-0003-4713-3911 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnmo.14955 |
PMID | 39491051 |
PQID | 3145509215 |
PQPubID | 1006536 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11650425 proquest_miscellaneous_3123803651 proquest_journals_3145509215 pubmed_primary_39491051 crossref_primary_10_1111_nmo_14955 wiley_primary_10_1111_nmo_14955_NMO14955 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2025 |
PublicationDateYYYYMMDD | 2025-01-01 |
PublicationDate_xml | – month: 01 year: 2025 text: January 2025 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford – name: Hoboken |
PublicationTitle | Neurogastroenterology and motility |
PublicationTitleAlternate | Neurogastroenterol Motil |
PublicationYear | 2025 |
Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
References | 2020; 8 2019; 4 2021; 97 2023; 14 2017; 3 2020; 2020 2020; 52 2021; 39 2021; 116 2022; 34 2020; 17 2019; 19 2020; 69 2020; 101 2020; 10 2023; 72 2016; 150 2016; 33 e_1_2_12_4_1 e_1_2_12_3_1 e_1_2_12_6_1 e_1_2_12_5_1 e_1_2_12_19_1 e_1_2_12_18_1 e_1_2_12_2_1 e_1_2_12_17_1 e_1_2_12_16_1 e_1_2_12_15_1 e_1_2_12_14_1 e_1_2_12_13_1 e_1_2_12_12_1 e_1_2_12_8_1 e_1_2_12_11_1 e_1_2_12_7_1 e_1_2_12_10_1 e_1_2_12_9_1 |
References_xml | – volume: 39 start-page: 382 issue: 4 year: 2021 end-page: 390 article-title: High prevalence of small intestinal bacterial overgrowth among functional dyspepsia patients publication-title: Dig Dis – volume: 3 year: 2017 article-title: Functional dyspepsia publication-title: Nat Rev Dis Prim – volume: 19 start-page: 239 issue: 1 year: 2019 article-title: Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study publication-title: BMC Microbiol – volume: 10 start-page: 151 year: 2020 article-title: Current sampling methods for gut microbiota: a call for more precise devices publication-title: Front Cell Infect Microbiol – volume: 72 start-page: 929 issue: 5 year: 2023 end-page: 938 article-title: Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia publication-title: Gut – volume: 14 year: 2023 article-title: Diversity of the microbiota communities found in the various regions of the intestinal tract in healthy individuals and inflammatory bowel diseases publication-title: Front Immunol – volume: 17 start-page: 261 issue: 3 year: 2020 end-page: 272 article-title: SciPy 1.0: fundamental algorithms for scientific computing in python publication-title: Nat Methods – volume: 34 issue: 11 year: 2022 article-title: Role of the duodenal microbiota in functional dyspepsia publication-title: Neurogastroenterol Motil – volume: 97 issue: 3 year: 2021 article-title: Is Oxford Nanopore sequencing ready for analyzing complex microbiomes? publication-title: FEMS Microbiol Ecol – volume: 101 start-page: 38 issue: 1 year: 2020 end-page: 45 article-title: Higher levels of streptococcus in upper gastrointestinal mucosa associated with symptoms in patients with functional dyspepsia publication-title: Digestion – volume: 150 start-page: 1380 issue: 6 year: 2016 end-page: 1392 article-title: Gastroduodenal Disorders publication-title: Gastroenterology – volume: 33 start-page: 1635 issue: 6 year: 2016 end-page: 1638 article-title: ETE 3: reconstruction, analysis, and visualization of Phylogenomic data publication-title: Mol Biol Evol – volume: 116 start-page: 935 issue: 5 year: 2021 end-page: 942 article-title: Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta‐analysis publication-title: Am J Gastroenterol – volume: 69 start-page: 591 issue: 3 year: 2020 end-page: 600 article-title: Novel concepts in the pathophysiology and treatment of functional dyspepsia publication-title: Gut – volume: 8 start-page: 691 issue: 5 year: 2020 article-title: Gut microbiota Dysbiosis in functional dyspepsia publication-title: Microorganisms – volume: 52 start-page: 155 issue: 1 year: 2020 end-page: 167 article-title: Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease publication-title: Aliment Pharmacol Ther – volume: 2020 year: 2020 article-title: NCBI taxonomy: a comprehensive update on curation, resources and tools publication-title: Database – volume: 4 issue: 36 year: 2019 article-title: Scikit‐posthocs: pairwise multiple comparison tests in python publication-title: J Open Source Software – ident: e_1_2_12_12_1 doi: 10.21105/joss.01169 – ident: e_1_2_12_11_1 doi: 10.1038/s41592-019-0686-2 – ident: e_1_2_12_9_1 doi: 10.1093/database/baaa062 – ident: e_1_2_12_6_1 doi: 10.1111/nmo.14372 – ident: e_1_2_12_19_1 doi: 10.1159/000504090 – ident: e_1_2_12_5_1 doi: 10.3390/microorganisms8050691 – ident: e_1_2_12_14_1 doi: 10.14309/ajg.0000000000001197 – ident: e_1_2_12_10_1 doi: 10.1093/molbev/msw046 – ident: e_1_2_12_8_1 doi: 10.1093/femsec/fiab001 – ident: e_1_2_12_7_1 doi: 10.1159/000511944 – ident: e_1_2_12_17_1 doi: 10.1186/s12866-019-1617-1 – ident: e_1_2_12_13_1 doi: 10.1111/apt.15786 – ident: e_1_2_12_4_1 doi: 10.1136/gutjnl-2019-318536 – ident: e_1_2_12_2_1 doi: 10.1053/j.gastro.2016.02.011 – ident: e_1_2_12_18_1 doi: 10.3389/fimmu.2023.1242242 – ident: e_1_2_12_15_1 doi: 10.1136/gutjnl-2021-326158 – ident: e_1_2_12_3_1 doi: 10.1038/nrdp.2017.81 – ident: e_1_2_12_16_1 doi: 10.3389/fcimb.2020.00151 |
SSID | ssj0006246 |
Score | 2.431325 |
Snippet | Background
Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms.... Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut... BackgroundFunctional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms.... Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e14955 |
SubjectTerms | Adult Age Chloroflexota DNA sequencing duodenal Duodenum - microbiology Dyspepsia Dyspepsia - microbiology Endoscopy Female Females functional Gastrointestinal Microbiome - genetics Gastrointestinal Microbiome - physiology Humans Intestinal microflora Irritable bowel syndrome Irritable Bowel Syndrome - microbiology Irritable Bowel Syndrome - physiopathology Male microbiome Microbiomes Middle Aged Original Relative abundance Sequence analysis Taxonomy Variance analysis |
Title | Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnmo.14955 https://www.ncbi.nlm.nih.gov/pubmed/39491051 https://www.proquest.com/docview/3145509215 https://www.proquest.com/docview/3123803651 https://pubmed.ncbi.nlm.nih.gov/PMC11650425 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9RAEB5qBfFFtPVHtMooIr5Ectkfl-BTUUsRroq00Lewm93YPFzuaHoP_Xf6l3Zmswk9iuBLLrB7JGR2Zr6d_fZbgI8EgVhFzJGLO51K48u0NLVMhdSZt41qasMF_cWJPj6TP8_V-Q58HffCDPoQU8GNPSPEa3ZwY_s7Tt4tV18Y3qsH8JC31vIgz-XvKQzrfNhaJFSWEoxRUVaIaTzTX7eT0T2EeZ8oeRfAhgx09BSeROiIh4Otn8GO7_Zg_7CjafPyGj9hIHOGKvkePFrENfN9uDm9aC8d_g360mwGjPRpSlpooiYJOs-rCT0yn4PZQ_TBcTw8hUIJth26zYqCFL3Bsh3Um5YemZEeaV8YKV_IqXKoMKK77td-3bcGo35rT090GPnx2G8sl4H653B29OP023EaT2ZIa0kYMHX0Y6TyuTEuE7nJhFO6MCydkwnWDDOitJbAzbx2vs6trqWZzeaFpsnMnE9ffAG73arzrwBr7XLd2CbTdi6N8kXR2JpgXk0fXcyET-DDaKJqPQhwVOPEhexYBTsmcDAar4o-2FciaLCXhGkSeD81k_fwkojp_GrDfQiyUBJXswReDraeniJKSViKW4qtUTB1YGXu7ZauvQgK3axpxNEwgc9hwPz7zauTxa9w8_r_u76BxzmfQhwKQQewe3W58W8JGl3Zd8EF6Pr9T34LhI0Q0g |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwEB2VIgEXBC0fgRYGhBCXoGzsOInEpapaLdBdOGyl3iIndmgOm1013UP_Dr-UGceJuqqQekokO0qUycw8j1_eAHwiCMQqYoZc3KhQapuHua5kKKSKbFkndaW5oD-bq-m5_HGRXOzAt-FfmF4fYiy4sWe4eM0OzgXpW17eLldfGd8nD-ChVHHKjRti-XuMwyru_y0SSRQSjkm8rhDzeMZLt7PRHYh5lyl5G8G6FHT6DJ567IhHvbGfw45t92D_qKV18_IGP6Njc7oy-R48mvlN8334u7hsrgz-cQLTbAf0_GnKWqi9KAkay9sJHTKhg-lD9MZx6J5CsQSbFs1mRVGKnmDZ9PJNS4tMSfe8L_ScL-Rc2ZcY0dx0a7vuGo1ewLWjOxr0BHnsNiXXgboXcH56sjiehr41Q1hJAoGhoYOWiY21NpGIdSRMojLN2jmRYNEwLfKyJHSTVsZWcakqqSeTNFO0mkm5_eJL2G1XrX0NWCkTq7qsI1WmUic2y-qyIpxX0UsXE2ED-DiYqFj3ChzFsHIhOxbOjgEcDMYrvBN2hXAi7DmBmgA-jMPkPrwnolu72vAcwiyUxZNJAK96W493EbkkMMUj2dZXME5gae7tkba5dBLdLGrE4TCAL-6D-f-TF_PZL3fy5v5T38Pj6WJ2Vpx9n_98C09ibknsqkIHsHt9tbGHhJOuy3fOHf4Bv68TVQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwEB2VIlVcELR8BAoMCCEuQdnY8SbiVAGr8rFLD63UW2THTpvDZldN99C_wy9lxnGiriokTolkR4k8npnn8cszwHuCQKwiZsnFrYqldkVc6ErGQqrEmTqrK80F_flCHZ_JH-fZ-Q58Hv6F6fUhxoIbe4aP1-zga1vfcvJ2ufrE8D67B_d5s4-ndypPxjCs0v7XIpElMcGYLMgKMY1nfHQ7Gd1BmHeJkrcBrM9As0fwMEBHPOpt_Rh2XLsPB0ctLZuXN_gBPZnTV8n3YW8e9swP4M_pZXNl8cLrS7MZMNCnKWmhDpokaB3vJnTIfA5mD9GA43B4CoUSbFq0mxUFKfqCZdOrNy0dMiM90L4wUL6QU2VfYUR7063dums0Bv3Wjt5oMfDjsdsYLgN1T-Bs9u30y3EcTmaIK0kYMLZ00TJzqdY2EalOhM1Urlk6JxGsGaZFYQyBm2llXZUaVUk9mUxzRYuZKZ---BR221XrngNWyqaqNnWizFTqzOV5bSqCeRUNupgIF8G7wUTluhfgKIeFC9mx9HaM4HAwXhl8sCuF12AvCNNE8HZsJu_hLRHdutWG-xBkoSSeTSJ41tt6fIsoJGEpbsm3ZsHYgZW5t1va5tIrdLOmEUfDCD76CfPvLy8X89_-5sX_d30DeydfZ-Wv74ufL-FBygcS-5rQIexeX23cK0JJ1-a194a_HgsShw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Third+generation+sequencing+analysis+detects+significant+differences+in+duodenal+microbiome+composition+between+functional+dyspepsia+patients+and+control+subjects&rft.jtitle=Neurogastroenterology+and+motility&rft.au=Tziatzios%2C+Georgios&rft.au=Stylianakis%2C+Emmanouil&rft.au=Damoraki%2C+Georgia&rft.au=Gkolfakis%2C+Paraskevas&rft.date=2025-01-01&rft.issn=1365-2982&rft.eissn=1365-2982&rft.volume=37&rft.issue=1&rft.spage=e14955&rft_id=info:doi/10.1111%2Fnmo.14955&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1350-1925&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1350-1925&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1350-1925&client=summon |